These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1674394)

  • 21. Propranolol in angina pectoris: duration of improved exercise tolerance and circulatory effects after acute oral administration.
    Thadani U; Parker JO
    Am J Cardiol; 1979 Jul; 44(1):118-25. PubMed ID: 377932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of nipradilol, a new beta-blocking agent with vasodilating properties, on exercise tolerance in patients with stable effort angina: a double-blind study.
    Araki H; Hayata N; Nakamura M
    Clin Ther; 1987; 9(6):656-62. PubMed ID: 2894246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative multicentre study of the tolerability and efficacy of epanolol versus metoprolol in patients with stable angina pectoris.
    Clark-Turner N
    Drugs; 1989; 38 Suppl 2():55-60. PubMed ID: 2575982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of once and twice daily oral dosing schedules of bevantolol, a new beta-adrenoceptor antagonist with alpha-adrenoceptor partial antagonist activity in patients with angina of effort.
    Molajo AO; Bray CL; Hillier V
    Int J Cardiol; 1989 Nov; 25(2):185-92. PubMed ID: 2572566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of a new adrenergic blocking agent (K4423) on exercise tolerance in angina pectoris.
    Libretti A; Gregorini L; Valentini R
    Cardiology; 1973; 58(6):369-75. PubMed ID: 4153721
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparison of the effect of a selective and a nonselective beta receptor blocker on the ischemic ST segment, lung function and stress-induced decrease in blood glucose].
    Brügmann U; Blasini R
    Herz; 1986 Feb; 11(1):55-61. PubMed ID: 2870014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of epanolol on intra-arterial ambulatory blood pressure and baroreceptor heart rate reflex in essential hypertension.
    Smith SA; Littler WA
    Clin Exp Pharmacol Physiol; 1988 Apr; 15(4):327-31. PubMed ID: 2908433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of partial agonist activity on the side effects of beta-blockade in patients with chronic stable angina.
    Chambers J; Ong ML; Akhras F; Adam G; Jackson G
    Drugs; 1989; 38 Suppl 2():39-44. PubMed ID: 2575979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihypertensive and hormonal responses to beta-blockade with intrinsic sympathomimetic activity: pindolol versus epanolol.
    Simon G; Wittig VJ
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):543-7. PubMed ID: 2447403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Duration of the effect and dose-response relationship of ridazolol in patients with coronary heart disease].
    Fach WA; Starke E; Becker HJ
    Z Kardiol; 1992 Jun; 81(6):320-5. PubMed ID: 1353933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propionyl carnitine in stable effort angina.
    Cherchi A; Lai C; Onnis E; Orani E; Pirisi R; Pisano MR; Soro A; Corsi M
    Cardiovasc Drugs Ther; 1990 Apr; 4(2):481-6. PubMed ID: 2285631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of beta-adrenoceptor blockade on heart rate and physiological tremor in diabetics with autonomic neuropathy. A comparative study of epanolol, atenolol and pindolol.
    Reid W; Ewing DJ; Harry JD; Smith HJ; Neilson JM; Clarke BF
    Br J Clin Pharmacol; 1987 Apr; 23(4):383-9. PubMed ID: 2883987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An overview of clinical trial experience with epanolol.
    Blake P
    Drugs; 1989; 38 Suppl 2():81-5. PubMed ID: 2575988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular function during treatment with either metoprolol or epanolol.
    Evans T
    Drugs; 1989; 38 Suppl 2():70. PubMed ID: 2575986
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical pharmacology of epanolol. Pharmacodynamic aspects.
    Harry JD
    Drugs; 1989; 38 Suppl 2():18-27. PubMed ID: 2575976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The efficacy of proxodolol, a new beta-adrenoblockader with alpha-adrenoblockader properties, in its single use in patients with stable stenocardia of effort].
    Metelitsa VI; Martsevich SIu; Kozyreva MP; Slastnikova ID; Vakulovskaia MK
    Eksp Klin Farmakol; 1994; 57(3):47-50. PubMed ID: 7914121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of metoprolol on the exercise tolerance in patients with stable angina pectoris (author's transl)].
    Tomei G; Mosti G; Veltri M; Giusti C
    G Ital Cardiol; 1978; 8(12):1286-92. PubMed ID: 367865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of epanolol versus metoprolol in angina pectoris. Results from the Swedish Multicenter Study of Exercise Tolerance. The Swedish Multicenter Study Group.
    Rydén L
    Drugs; 1989; 38 Suppl 2():66. PubMed ID: 2575984
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris.
    Thadani U; Davidson C; Singleton W; Taylor SH
    Am J Med; 1980 Feb; 68(2):243-50. PubMed ID: 6101934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sustained effect of nitroglycerin ointment on exercise tolerance in patients with effort angina (author's transl)].
    Previtali M; Salerno JA; Falcone C; Lepore R; Chimienti M; Medici A; Angoli L; Bobba P
    G Ital Cardiol; 1980; 10(5):584-91. PubMed ID: 6778754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.